247P KN026 in combination with docetaxel as neoadjuvant treatment for HER2+ early or locally advanced breast cancer (BC): A single-arm, multicenter, phase II study

DOI: 10.1016/j.annonc.2023.09.445 Publication Date: 2023-10-20T11:29:41Z